DermTech, Inc. announced that Dr. John Dobak expects to step away from his role as president and director under a planned transition. Dr. John Dobak will continue to serve as president and director until the earlier of the date the Board appoints a successor and September 30, 2023. The Board has initiated a comprehensive search to identify Dr. Dobak's replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3188 USD | +0.57% | -5.82% | -81.78% |
14/05 | DermTech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/05 | Earnings Flash (DMTK) DERMTECH Posts Q1 Revenue $3.8M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.78% | 1.11Cr | |
-9.74% | 1.15TCr | |
-9.80% | 763.88Cr | |
+27.84% | 549.37Cr | |
-15.47% | 385.56Cr | |
+8.47% | 260.73Cr | |
-63.81% | 242.41Cr | |
-9.24% | 227.09Cr | |
+21.21% | 209.98Cr | |
-9.38% | 176.43Cr |
- Stock Market
- Equities
- DMTK Stock
- News DermTech, Inc.
- DermTech, Inc. Announces John Dobak Expects to Step Away as President and Director